On May 29, 2024, Ultralife Corporation filed a definitive proxy statement soliciting proxies and urged the shareholders to vote against a shareholder proposal, requesting that the Board of Directors initiate the appropriate process as soon as possible to amend the Company?s articles of incorporation and/or bylaws to provide that director nominees shall be elected by the affirmative vote of the majority of votes cast at an annual meeting of stockholders, with a plurality vote standard retained for contested director elections, that is, when the number of director nominees exceeds the number of board seats, submitted by Kenneth Steiner at the Company?s annual shareholders meeting scheduled to be held on July 16, 2024.